# CORRESP — Aptevo Therapeutics Inc.  (APVO)  (CIK 0001671584)

> <strong>Aptevo Therapeutics Inc.  (APVO)  (CIK 0001671584) → SEC staff</strong> · filed 2026-08-31 · ticker APVO · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-26-377083
- **Form:** CORRESP
- **Filer:** Aptevo Therapeutics Inc.  (APVO)  (CIK 0001671584)
- **CIK:** 0001671584
- **Ticker:** APVO
- **Filed:** 2026-08-31
- **SIC industry:** 2834
- **HQ:** Seattle, WA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1671584/000119312526377083/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1671584&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Aptevo Therapeutics Inc.  (APVO)  (CIK 0001671584)

- UPLOAD — 2026-08-27 — /comment-letter/0000000000-26-008467
- CORRESP — 2025-11-24 — /comment-letter/0001193125-25-293460

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Aptevo Therapeutics Inc.  (APVO)  (CIK 0001671584) (CIK 0001671584), filed 2026-08-31, accession 0001193125-26-377083. Retrieved via MORVS 2026-11-17 from https://api.morvs.ai/comment-letter/0001193125-26-377083.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
